FierceBiotech22h
Biogen axes asset from $7.3B buyout, along with Alzheimer’s and Parkinson’s prospects
BIIB143, also known as cemdomespib, was the most advanced asset to get the chop. Biogen acquired the Hsp90 modulator in 2023 through its buyout of Reata, a deal that centered on the FDA-approved ...
Parkinson’s Disease Market is anticipated to Grow at a CAGR of 5.8% During the Study Period (2020-2034) by DelveInsight
According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...
Knowridge6d
Research shows major causes of Parkinson’s disease and dementia
Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...
AstraZeneca’s diabetes drug fails to slow Parkinson’s progression in UCL trial
Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
Knowridge8d
New research links kidney failure to Parkinson’s disease
Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...
News Medical13d
Alzheimer’s and Parkinson’s linked to aging brain’s failing waste disposal
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
Inhibikase Halts Parkinson's Drug Development to Focus on PAH
Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...
Medical Xpress15d
Parkinson's Disease
A Colorado Springs family hopes to win what they believe would be a landmark legal verdict by proving to jurors next month that mold exposure in a rented apartment caused Parkinson's disease in a ...
Hosted on MSN17d
Parkinson's disease could be treated by FDA-approved cancer drug after major research breakthrough
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...
C&EN19d
Chronic DSS-Induced Colitis Exacerbates Parkinson’s Disease Phenotype and Its Pathological Features Following Intragastric Rotenone Exposure
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad 382355, Gujarat, India Department of Pharmacology and Toxicology, College of ...
Medscape20d
Proteomic Analysis of Mitochondrial Dysfunction in Neurogenerative Diseases
Lewy bodies Intra-cytoplasmic (neurons) α-synuclein Parkinson's disease Lewy bodies Intra-cytoplasmic (neurons) α-synuclein Complex I and IV deficiency Huntington's disease Neuronal intra ...
Frontiers21d
Brain network and energy imbalance in Parkinson’s disease: linking ATP reduction and α-synuclein pathology
2023). In summary, disruption of ATP homeostasis plays a multifaceted role in α-synuclein aggregation and the progression of Parkinson’s disease. ATP not only serves as a biological hydrotrope, ...